Randomized multicenter phase II trial of oxaliplatin plus irinotecan versus raltitrexed as first-line treatment in advanced colorectal cancer. [electronic resource]
Producer: 20020201Description: 165-72 p. digitalISSN:- 0732-183X
- Adenocarcinoma -- drug therapy
- Adult
- Aged
- Antimetabolites, Antineoplastic -- therapeutic use
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Camptothecin -- administration & dosage
- Colorectal Neoplasms -- drug therapy
- Cross-Over Studies
- Disease-Free Survival
- Dose-Response Relationship, Drug
- Drug Synergism
- Female
- Humans
- Irinotecan
- Male
- Middle Aged
- Organoplatinum Compounds -- administration & dosage
- Oxaliplatin
- Palliative Care
- Quinazolines -- therapeutic use
- Survival Rate
- Thiophenes -- therapeutic use
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.